Literature DB >> 9112473

A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate.

A van't Riet1, A C Mak, M A Moerland, L H Elders, W van der Zee.   

Abstract

PURPOSE: This article presents a method of quantitative assessment of the degree of conformality and its designation by a single numerical value. METHODS AND MATERIALS: A conformation number is introduced to evaluate objectively the degree of conformality. A comparison is made between the conformation number as found for external beam treatment plans and ultrasonically guided 125I seed implants for localized prostate cancer.
RESULTS: The conformation number in case of a planning target volume irradiated with two opposed open beams, three open beams, and three beams with customized blocks amounted to 0.17, 0.39, and 0.65, respectively. The conformation number as found for ultrasonically guided permanent prostate implants using 125I seeds averaged 0.72.
CONCLUSIONS: The conformation number is a convenient instrument for indicating the degree of conformality by a single numerical value. Treatments with a conformation number greater than 0.60 might be termed conformal radiotherapy.

Entities:  

Mesh:

Year:  1997        PMID: 9112473     DOI: 10.1016/s0360-3016(96)00601-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  215 in total

1.  Comparison of total MU and segment areas in VMAT and step-and-shoot IMRT plans.

Authors:  Motohiro Kawashima; Shuichi Ozawa; Akihiro Haga; Akira Sakumi; Chie Kurokawa; Satoru Sugimoto; Kumiko Karasawa; Keiichi Nakagawa; Keisuke Sasai
Journal:  Radiol Phys Technol       Date:  2012-07-01

2.  Human-computer interaction in radiotherapy target volume delineation: a prospective, multi-institutional comparison of user input devices.

Authors: 
Journal:  J Digit Imaging       Date:  2011-10       Impact factor: 4.056

3.  A split-parotid delineation approach for dose optimization in volumetric modulated arc therapy for nasopharyngeal carcinoma patients with parapharyngeal space invasion and level IIa cervical lymph node involvements.

Authors:  Wei Xiao; Zhixiong Lin; Wuzhe Zhang; Mei Li; Vincent W C Wu
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

4.  Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer.

Authors:  Su Yu Zhu; Takashi Mizowaki; Yoshiki Norihisa; Kenji Takayama; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

5.  Improving IMRT delivery efficiency with reweighted L1-minimization for inverse planning.

Authors:  Hojin Kim; Stephen Becker; Rena Lee; Soonhyouk Lee; Sukyoung Shin; Emmanuel Candès; Lei Xing; Ruijiang Li
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

6.  Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study.

Authors:  Alonso N Gutiérrez; David C Westerly; Wolfgang A Tomé; Hazim A Jaradat; Thomas R Mackie; Søren M Bentzen; Deepak Khuntia; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-01       Impact factor: 7.038

7.  New possibilities for volumetric-modulated arc therapy using the Agility™ 160-leaf multileaf collimator.

Authors:  Nadine Blümer; Christian Scherf; Janett Köhn; Eugen Kara; Britta Loutfi-Krauß; Detlef Imhoff; Claus Rödel; Ulla Ramm; Jörg Licher
Journal:  Strahlenther Onkol       Date:  2014-07-25       Impact factor: 3.621

8.  The relation between various conformity indices and the influence of the target coverage difference in prescription isodose surface on these values in intracranial stereotactic radiosurgery.

Authors:  K Ohtakara; S Hayashi; H Hoshi
Journal:  Br J Radiol       Date:  2011-09-21       Impact factor: 3.039

9.  Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy.

Authors:  Christos Moustakis; Oliver Blanck; Fatemeh Ebrahimi Tazehmahalleh; Mark Ka Heng Chan; Iris Ernst; Thomas Krieger; Marciana-Nona Duma; Markus Oechsner; Ute Ganswindt; Christian Heinz; Horst Alheit; Hilbert Blank; Ursula Nestle; Rolf Wiehle; Christine Kornhuber; Christian Ostheimer; Cordula Petersen; Gerhard Pollul; Wolfgang Baus; Georg Altenstein; Eric Beckers; Katrin Jurianz; Florian Sterzing; Matthias Kretschmer; Heinrich Seegenschmiedt; Torsten Maass; Stefan Droege; Ulrich Wolf; Juergen Schoeffler; Uwe Haverkamp; Hans Theodor Eich; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2017-05-31       Impact factor: 3.621

10.  Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?

Authors:  Enzhuo M Quan; Joe Y Chang; Zhongxing Liao; Tingyi Xia; Zhiyong Yuan; Hui Liu; Xiaoqiang Li; Cody A Wages; Radhe Mohan; Xiaodong Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.